A detailed history of Aventura Private Wealth, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Aventura Private Wealth, LLC holds 273 shares of BIIB stock, worth $45,741. This represents 0.02% of its overall portfolio holdings.

Number of Shares
273
Holding current value
$45,741
% of portfolio
0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 07, 2026

BUY
$142.26 - $167.55 $38,836 - $45,741
273 New
273 $48 Million
Q3 2025

Jan 07, 2026

SELL
$122.68 - $148.84 $4,293 - $5,209
-35 Reduced 8.71%
367 $51.4 Million
Q2 2025

Jan 07, 2026

SELL
$113.38 - $135.49 $15,646 - $18,697
-138 Reduced 25.56%
402 $50.5 Million
Q1 2025

Jan 07, 2026

BUY
$133.43 - $153.27 $35,625 - $40,923
267 Added 97.8%
540 $73.9 Million
Q4 2024

Jan 07, 2026

BUY
$146.47 - $191.55 $47,749 - $62,445
326 Added 119.41%
599 $91.6 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $24.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Aventura Private Wealth, LLC Portfolio

Follow Aventura Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aventura Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aventura Private Wealth, LLC with notifications on news.